Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Prostate Cancer
Findings from University of Louvain in prostate cancer reported
December 25th, 2008
"Toremifene citrate is an oral selective estrogen receptor modulator (SERM) that is used to block the actions of estrogens. In women, torernifene is used in the treatment of advanced (metastatic) breast cancer, osteoporosis, and dyslipidaernia of postmenopausal women," scientists in Brussels, Belgium report. "The possibility that toremifene could prevent side effects of androgen deprivation therapy (ADT) in men with advanced prostate cancer (PCa) is currently being tested in a large cohort of men (n = 1389). Smith et al have recently reported the result of an interim analysis on 188 patients from this trial in which detailed analysis of fasting serum lipids was...
Source: Women's Health Weekly (2008-12-25)
|
